259 related articles for article (PubMed ID: 35163222)
1. Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.
Korfiati A; Grafanaki K; Kyriakopoulos GC; Skeparnias I; Georgiou S; Sakellaropoulos G; Stathopoulos C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163222
[TBL] [Abstract][Full Text] [Related]
2. Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF; Belitskaya-Lévy I; Rose AE; Zakrzewski J; Gaziel A; Hanniford D; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Osman I; Hernando E
Clin Cancer Res; 2010 Mar; 16(5):1577-86. PubMed ID: 20179230
[TBL] [Abstract][Full Text] [Related]
3. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
[TBL] [Abstract][Full Text] [Related]
6. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNA profiling in prediction of tumor recurrence and progress and bioinformatics analysis for patients with primary esophageal cancer: Study based on TCGA database.
Chen F; Zhou H; Wu C; Yan H
Pathol Res Pract; 2018 Dec; 214(12):2081-2086. PubMed ID: 30477645
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis.
Polini B; Carpi S; Romanini A; Breschi MC; Nieri P; Podestà A
Pigment Cell Melanoma Res; 2019 Jul; 32(4):486-499. PubMed ID: 30481404
[TBL] [Abstract][Full Text] [Related]
9. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS
Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Loginov VI; Pronina IV; Filippova EA; Burdennyy AM; Lukina SS; Kazubskaya TP; Uroshlev LA; Fridman MV; Brovkina OI; Apanovich NV; Karpukhin AV; Stilidi IS; Kushlinskii NE; Dmitriev AA; Braga EA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163224
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
[TBL] [Abstract][Full Text] [Related]
12. Combining Supervised and Unsupervised Learning for Improved miRNA Target Prediction.
Sedaghat N; Fathy M; Modarressi MH; Shojaie A
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(5):1594-1604. PubMed ID: 28715336
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Profile in Conjunctival Melanoma.
Larsen AC; Mikkelsen LH; Borup R; Kiss K; Toft PB; von Buchwald C; Coupland SE; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4205-12. PubMed ID: 27548891
[TBL] [Abstract][Full Text] [Related]
14. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
[TBL] [Abstract][Full Text] [Related]
15. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of deregulated microRNAs in uveal melanomas.
Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
[TBL] [Abstract][Full Text] [Related]
17. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Fleming NH; Zhong J; da Silva IP; Vega-Saenz de Miera E; Brady B; Han SW; Hanniford D; Wang J; Shapiro RL; Hernando E; Osman I
Cancer; 2015 Jan; 121(1):51-9. PubMed ID: 25155861
[TBL] [Abstract][Full Text] [Related]
18. Melanoma Explorer: a web application to allow easy reanalysis of publicly available and clinically annotated melanoma omics data sets.
Strbenac D; Wang K; Wang X; Dong J; Mann GJ; Mueller S; Yang JYH
Melanoma Res; 2019 Jun; 29(3):342-344. PubMed ID: 31026248
[TBL] [Abstract][Full Text] [Related]
19. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
